[EN] BORYLATED DI-PEPTIDE AMINO ACID COMPOSITIONS FOR USE IN BORON NEUTRON CAPTURE THERAPY AND METHODS THEREOF [FR] COMPOSITIONS D'ACIDES AMINÉS DIPEPTIDIQUES BORYLÉS DESTINÉES À ÊTRE UTILISÉES EN THÉRAPIE PAR CAPTURE DE NEUTRONS PAR LE BORE ET MÉTHODES ASSOCIÉES
摘要:
Borylated Di-Peptide Amino Acid ("Bdi-AA") compositions and Di-Peptide Amino Acid (di-AA) compositions and methods of making Bdi-AAs and di-AAs are disclosed herein. Consequently, the Bdi-AAs and di-AAs can be administered to patients as a Neutron Capture Agent and provide a method of treating cancer, immunological disorders, and other disease by utilizing a Neutron Capture Therapy modality.
[EN] BORYLATED DI-PEPTIDE AMINO ACID COMPOSITIONS FOR USE IN BORON NEUTRON CAPTURE THERAPY AND METHODS THEREOF [FR] COMPOSITIONS D'ACIDES AMINÉS DIPEPTIDIQUES BORYLÉS DESTINÉES À ÊTRE UTILISÉES EN THÉRAPIE PAR CAPTURE DE NEUTRONS PAR LE BORE ET MÉTHODES ASSOCIÉES
摘要:
Borylated Di-Peptide Amino Acid ("Bdi-AA") compositions and Di-Peptide Amino Acid (di-AA) compositions and methods of making Bdi-AAs and di-AAs are disclosed herein. Consequently, the Bdi-AAs and di-AAs can be administered to patients as a Neutron Capture Agent and provide a method of treating cancer, immunological disorders, and other disease by utilizing a Neutron Capture Therapy modality.
[EN] BORYLATED DI-PEPTIDE AMINO ACID COMPOSITIONS FOR USE IN BORON NEUTRON CAPTURE THERAPY AND METHODS THEREOF<br/>[FR] COMPOSITIONS D'ACIDES AMINÉS DIPEPTIDIQUES BORYLÉS DESTINÉES À ÊTRE UTILISÉES EN THÉRAPIE PAR CAPTURE DE NEUTRONS PAR LE BORE ET MÉTHODES ASSOCIÉES
申请人:[en]TAE LIFE SCIENCES
公开号:WO2023113843A2
公开(公告)日:2023-06-22
Borylated Di-Peptide Amino Acid ("Bdi-AA") compositions and Di-Peptide Amino Acid (di-AA) compositions and methods of making Bdi-AAs and di-AAs are disclosed herein. Consequently, the Bdi-AAs and di-AAs can be administered to patients as a Neutron Capture Agent and provide a method of treating cancer, immunological disorders, and other disease by utilizing a Neutron Capture Therapy modality.